Simplex Trading’s ProPhase Labs PRPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-7,431
| Closed | -$3.33K | – | 9917 |
|
|
2025
Q4 | $3.33K | Buy |
7,431
+3,371
| +83% | +$9.49K | ﹤0.01% | 7637 |
|
|
2025
Q3 | $18K | Buy |
4,060
+2,899
| +250% | +$11.2K | ﹤0.01% | 7416 |
|
|
2025
Q2 | $4K | Buy |
1,161
+527
| +83% | +$1.76K | ﹤0.01% | 7882 |
|
|
2025
Q1 | $2K | Buy |
634
+475
| +299% | +$2.18K | ﹤0.01% | 8049 |
|
|
2024
Q4 | $1K | Buy |
159
+148
| +1,345% | +$2.08K | ﹤0.01% | 8294 |
|
|
2024
Q3 | $0 | Sell |
11
-313
| -97% | -$8.81K | ﹤0.01% | 9338 |
|
|
2024
Q2 | $13K | Buy |
324
+284
| +710% | +$14.9K | ﹤0.01% | 7259 |
|
|
2024
Q1 | $2K | Sell |
40
-289
| -88% | -$14.6K | ﹤0.01% | 8442 |
|
|
2023
Q4 | $14K | Buy |
329
+10
| +3% | +$456 | ﹤0.01% | 7199 |
|
|
2023
Q3 | $13K | Sell |
319
-139
| -30% | -$8.14K | ﹤0.01% | 7001 |
|
|
2023
Q2 | $33K | Buy |
+458
| New | +$37.3K | ﹤0.01% | 6263 |
|
|
2023
Q1 | – | Sell |
-85
| Closed | -$6.85K | – | 9891 |
|
|
2022
Q4 | $8K | Sell |
85
-26
| -23% | -$2.81K | ﹤0.01% | 7745 |
|
|
2022
Q3 | $12K | Sell |
111
-78
| -41% | -$9.07K | ﹤0.01% | 8087 |
|
|
2022
Q2 | $23K | Buy |
+189
| New | +$16.6K | ﹤0.01% | 7450 |
|
|
2022
Q1 | – | Sell |
-155
| Closed | -$10.8K | – | 11188 |
|
|
2021
Q4 | $11K | Buy |
+155
| New | +$9.65K | ﹤0.01% | 8951 |
|
|
2021
Q2 | – | Sell |
-450
| Closed | -$25.3K | – | 10569 |
|
|
2021
Q1 | $33K | Buy |
+450
| New | +$43.2K | ﹤0.01% | 7044 |
|
Other funds holding PRPH
Simplex Trading's PRPH Position: Q1 2026 in Review
Simplex Trading sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 7,431 shares — an estimated $3.33K sold.
Simplex Trading first reported a position in PRPH in Q1 2021 and held it in 16 quarters. The position peaked at $33K in Q2 2023. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.
- Simplex Trading reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 7,431 ProPhase Labs shares in Q1 2026, an estimated $3.33K.
- Simplex Trading first reported a position in ProPhase Labs in Q1 2021 and held it in 16 quarters.
- Simplex Trading's ProPhase Labs position peaked at $33K in Q2 2023.
- 2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.